Nordson (NDSN) Earnings Analysis
Nordson (NDSN) next reports earnings on 2026-08-19, consensus EPS 3.05 USD. Last quarter (2026-05-20) it beat with EPS 2.86 USD vs 2.82 USD est (+1.4%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E 30.99.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NDSN next report earnings?
| Next earnings date | 2026-08-19 |
|---|---|
| Consensus EPS estimate | 3.05 USD |
| Revenue estimate | 0.78B |
NDSN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-20 | 2.86 USD | 2.82 USD | +1.4% | Beat |
| 2026-02-18 | 2.37 USD | 2.37 USD | 0% | Beat |
| 2025-12-10 | 3.03 USD | 2.93 USD | +3.4% | Beat |
| 2025-08-20 | 2.73 USD | 2.64 USD | +3.4% | Beat |
| 2025-05-28 | 2.42 USD | 2.36 USD | +2.5% | Beat |
| 2025-02-19 | 2.06 USD | 2.09 USD | -1.4% | Miss |
| 2024-12-11 | 2.78 USD | 2.59 USD | +7.3% | Beat |
| 2024-08-21 | 2.41 USD | 2.33 USD | +3.4% | Beat |
Beat rate: 7/8 (88%) over reported quarters with consensus data.
NDSN valuation and analyst view
| Trailing P/E | 30.99 |
|---|---|
| Trailing EPS | 9.466 USD |
| Price / book | 5.08 |
| Dividend yield | 1.12% |
| Market cap | 16.24B |
| Analyst consensus | Buy (13 buy / 8 hold / 0 sell) |
| Avg price target | 340 USD |
Related research pages
Frequently asked questions
When is Nordson (NDSN)'s next earnings date?
Nordson is next scheduled to report on 2026-08-19, with a consensus EPS estimate of 3.05 USD and revenue estimate of 0.78B.
Did NDSN beat earnings last quarter?
In its 2026-05-20 report, NDSN posted EPS of 2.86 USD versus a 2.82 USD estimate — a beat of 1.4%.
What is NDSN's earnings track record?
Over the last 8 reported quarters with consensus data, NDSN beat estimates 7 times (88%).
What is NDSN's current P/E ratio and EPS?
NDSN trades at a trailing P/E of 30.99 on trailing EPS of 9.46563188930511 USD.
What do analysts rate NDSN?
Analyst consensus is "Buy" across 21 ratings (0 strong buy, 13 buy, 8 hold, 0 sell, 0 strong sell). Average 12-month price target: 340 USD.